medicaid glp-1 McKee's proposed FY2027 budget drops drugs for weight loss from • Rhode Island Current Have you heard? GLP1 medicines

The 4 mg group lost 17.1%

Lieverse R, Jansen J, Masclee A, Lamers C

Support the GLP-1 Bacteria ( Akkermansia ) The Science: Emerging research from 2024 and 2025 has identified a specific strain of gut bacteria, Akkermansia muciniphila , which plays a pivotal role in metabolic health and natural weight management

For GLP-1 medications, insurers may require evidence that the patient has tried other treatments or that the medication is essential for managing weight loss in the presence of other conditions like type 2 diabetes, hypertension, or cardiovascular disease

comprises an inordinate proportion of brand name drug revenue and profits because domestic prices are so high